Pharmacokinetic Monitoring – Peak & Trough Concentrations
Peak (Highest Plasma Concentration)
Definition
- Moment at which a drug reaches its highest concentration in plasma (often annotated as C_{\text{max}}).
- Represents the culmination of absorption before distribution, metabolism, and elimination start to dominate.
Why It Matters
- Therapeutic Assessment ➜ Confirms that the concentration is high enough to produce the desired clinical effect without crossing toxic thresholds.
- Guides Next-Dose Planning ➜ Determines when and how much to give in the subsequent dose to maintain efficacy.
- Safety Window Check ➜ Ensures peak does not exceed the upper limit of the therapeutic index.
- Indirect Indicator of Absorption Rate ➜ A delayed or blunted peak can hint at malabsorption or drug-drug/food interactions.
Expanded Context / Connections
- In prior pharmacokinetic discussions, peak is affected by:
• Route of administration (IV bolus gives an immediate peak; oral yields a delayed peak).
• First-pass metabolism (hepatic clearance lowers apparent peak for many oral drugs). - Clinically monitored for antibiotics (e.g.
gentamicin) and anticonvulsants (e.g.
phenytoin) to avoid toxicity. - Ethical Consideration: Overtreatment leading to toxic peaks violates non-maleficence.
- In prior pharmacokinetic discussions, peak is affected by:
Trough (Lowest Plasma Concentration)
Definition
- The lowest concentration of a drug in plasma immediately before the next scheduled dose (often denoted C_{\text{min}}).
- Reflects the combined impact of distribution, metabolism, and elimination.
Why It Matters
- Efficacy Check ➜ Confirms the drug remains above minimum effective concentration (MEC) for the entire dosing interval.
- Dose Adequacy ➜ If trough falls below MEC, the prescribed dose or frequency may be insufficient.
- Elimination Rate Indicator ➜ Rapid declines to a low trough suggest accelerated clearance (e.g.
in hyper-metabolic states, drug interactions, or organ impairment). - Toxicology Balance ➜ A high trough may signal accumulation and impending toxicity.
Expanded Context / Connections
- Previous lectures on elimination constants (k) and half-life (t{1/2}) show that:
C{\text{trough}} = C_{\text{peak}} e^{-k \Delta t}
where \Delta t is time between peak and trough. - Used heavily in therapeutic drug monitoring (TDM) for narrow-index drugs (e.g.
vancomycin, digoxin). - Practical/ethical implication: Ensuring sub-toxic yet effective levels supports patient safety and stewardship against resistance (antibiotics).
- Previous lectures on elimination constants (k) and half-life (t{1/2}) show that:
C{\text{trough}} = C_{\text{peak}} e^{-k \Delta t}
Integrated Take-Home Points
Peak & Trough Together
- Provide a two-point snapshot of the drug’s concentration–time profile within a single dosing interval.
- Facilitate fine-tuning of dose, interval, and route to maximize benefit and minimize harm.
- Form the backbone of individualized pharmacokinetic dosing algorithms.
Clinical Workflow
- Draw trough level right before next dose.
- Administer dose, then draw peak sample at the drug-specific time post-administration (e.g.
30 min after IV, 1–2 h after oral). - Compare values to established therapeutic range.
- Adjust regimen accordingly.
Mnemonic
- "Trough = Time to re-dose" (lowest point triggers next administration).
- "Peak = Potential for toxicity" (watch the ceiling!).